STOCK TITAN

Gilead Pays Tribute to Patient Advocacy Work: Cara’s Story

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Gilead Sciences (GILD) Honors Cancer Patient with Conference Room Naming
Positive
  • None.
Negative
  • None.

NORTHAMPTON, MA / ACCESSWIRE / January 10, 2024 / Gilead Sciences:

When employees at Gilead's recently opened New Jersey office need a place to meet, the "Cara" conference room is one such place they gather. Given the room's namesake, it's especially fitting when the topic at hand is the company's oncology work.

A Pennsylvania mother of two young children, Cara was diagnosed with triple-negative breast cancer in 2018. She learned the following year that it had metastasized to her brain. But Cara says she isn't just surviving with metastatic triple-negative breast cancer - she's thriving and using her diagnosis as a way to help others.

After developing a passion for patient advocacy, Cara became president of 412Thrive, a Pittsburgh-based nonprofit that provides care packages for breast cancer patients as they navigate challenges like chemotherapy and radiation.

"The best thing from this whole diagnosis is that I'm able to volunteer my time to help others," says Cara.

The room in the Parsippany, New Jersey office was named after Cara to honor her perseverance and commitment to helping others. Each conference room on the two floors was named after a patient or advocate - serving as a visual reminder for Gilead employees of the communities they serve.

"It's such an honor because I feel like I've done some great advocacy work," says Cara. "It makes this journey so much more to know that I'm making a difference."

Watch the video above to see Cara's full story.

Originally published by Gilead Sciences

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:

Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com

SOURCE: Gilead Sciences



View the original press release on accesswire.com

FAQ

Who is Gilead Sciences and what is their ticker symbol?

Gilead Sciences is a biopharmaceutical company known for its work in developing innovative medicines. The ticker symbol for Gilead Sciences is GILD.

What is the significance of the 'Cara' conference room at Gilead's New Jersey office?

The 'Cara' conference room is named after a patient, Cara, who was diagnosed with triple-negative breast cancer and became a president of a nonprofit that provides care packages for breast cancer patients.

What is 412Thrive and how is Cara involved with it?

412Thrive is a Pittsburgh-based nonprofit that provides care packages for breast cancer patients, and Cara is the president of the organization.

How does Gilead honor patients and advocates in their office?

Gilead names each conference room after a patient or advocate, serving as a visual reminder for employees of the communities they serve.

What is Cara's perspective on her cancer diagnosis?

Cara sees her diagnosis as an opportunity to help others and has become a passionate advocate for patient care.

Gilead Sciences Inc

NASDAQ:GILD

GILD Rankings

GILD Latest News

GILD Stock Data

81.73B
1.24B
0.09%
88.37%
1.81%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
FOSTER CITY

About GILD

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.